The participants will be asked at the end of the active intervention phase (three months from the date of randomization) and at the end of the study period (nine months from the date of randomization) about their functional status, history of falls, cognitive impairment, quality of life, health care utilization, and medical history by the blinded assessors. Recurrent falls incidence will be monitored by participants' self-reporting monthly falls diary as well as monthly phone calls conducted by the study coordinator during the entire study period.